Chronic Lymphocytic Leukemia Highlights From ASH 2022 Chronic Lymphocytic Leukemia Highlights From ASH 2022

Dr Jan Burger reports on key data in chronic lymphocytic leukemia from ASH 2022, focusing on treatment-free remission, triple combination therapy, and BTK inhibitors pirtobrutinib and zanubrutinib.Medscape

Source: Medscape Today Headlines - January 4, 2023 Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news